<!DOCTYPE html>
<!-- saved from url=(0014)about:internet -->
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

<title>Epidemiology Class Notes 2012-09-20</title>

<base target="_blank"/>

<style type="text/css">
body, td {
   font-family: sans-serif;
   background-color: white;
   font-size: 12px;
   margin: 8px;
}

tt, code, pre {
   font-family: 'DejaVu Sans Mono', 'Droid Sans Mono', 'Lucida Console', Consolas, Monaco, monospace;
}

h1 { 
   font-size:2.2em; 
}

h2 { 
   font-size:1.8em; 
}

h3 { 
   font-size:1.4em; 
}

h4 { 
   font-size:1.0em; 
}

h5 { 
   font-size:0.9em; 
}

h6 { 
   font-size:0.8em; 
}

a:visited {
   color: rgb(50%, 0%, 50%);
}

pre {	
   margin-top: 0;
   max-width: 95%;
   border: 1px solid #ccc;
}

pre code {
   display: block; padding: 0.5em;
}

code.r {
   background-color: #F8F8F8;
}

table, td, th {
  border: none;
}

blockquote {
   color:#666666;
   margin:0;
   padding-left: 1em;
   border-left: 0.5em #EEE solid;
}

hr {
   height: 0px;
   border-bottom: none;
   border-top-width: thin;
   border-top-style: dotted;
   border-top-color: #999999;
}

@media print {
   * { 
      background: transparent !important; 
      color: black !important; 
      filter:none !important; 
      -ms-filter: none !important; 
   }

   body { 
      font-size:12pt; 
      max-width:100%; 
   }
       
   a, a:visited { 
      text-decoration: underline; 
   }

   hr { 
      visibility: hidden;
      page-break-before: always;
   }

   pre, blockquote { 
      padding-right: 1em; 
      page-break-inside: avoid; 
   }

   tr, img { 
      page-break-inside: avoid; 
   }

   img { 
      max-width: 100% !important; 
   }

   @page :left { 
      margin: 15mm 20mm 15mm 10mm; 
   }
     
   @page :right { 
      margin: 15mm 10mm 15mm 20mm; 
   }

   p, h2, h3 { 
      orphans: 3; widows: 3; 
   }

   h2, h3 { 
      page-break-after: avoid; 
   }
}

</style>





</head>

<body>
<h1>Epidemiology Class Notes 2012-09-20</h1>

<h2>Pop Quiz</h2>

<ul>
<li>What does &ldquo;aetiological&rdquo; mean?</li>
<li>In doing a prognostic or survival study, would you adopt a case-control, a cross-sectional, or a cohort design?</li>
<li>What are &ldquo;hospital controls&rdquo;?</li>
</ul>

<h2>Basic Research Designs</h2>

<h1>Descriptive versus Analytic.  Introduction to the Island.</h1>

<h1>Interventional</h1>

<p>The classical experiment:</p>

<ul>
<li>Treatment and Control</li>
<li>Randomization (why)</li>
</ul>

<h3>Details:</h3>

<ul>
<li>Crossover design</li>
<li>Historical &ldquo;controls&rdquo;</li>
</ul>

<h1>Observational</h1>

<ul>
<li>Cross-sectional</li>
<li>Cohort </li>
<li>Case-Control</li>
<li>Ecological</li>
<li>Record linkage</li>
<li>Case-crossover.</li>
</ul>

<h3>SMALL GROUP DISCUSSION:</h3>

<p>You have been tasked by President Rosenberg to find out if the Writing requirement is effective at Macalester.  You have access to students and to the registrar&#39;s records.  </p>

<ul>
<li>You have one week to give your report.  Design an appropriate study.</li>
<li>You have one year to give your report.  Design an appropriate study.</li>
</ul>

<h2>Ethics:</h2>

<ul>
<li><p><a href="http://en.wikipedia.org/wiki/Nuremberg_Code">Nuremberg Code</a> </p>

<ul>
<li>Work through the basics:

<ul>
<li>voluntary consent.</li>
<li>Beneficence</li>
<li>Plausibility and scientific basis</li>
</ul></li>
<li>Note the qualifications: ¶4 &ldquo;avoid all <strong>unnecessary</strong> physical and mental suffering and injury&rdquo;; ¶5 &ldquo;death or disabling injury will occur&rdquo; (as opposed to &ldquo;may occur&rdquo;); ¶6 the &ldquo;degree of risk to be taken&rdquo;</li>
<li>Some things seem odd today. Note especially ¶5. </li>
</ul></li>
<li><p>Declaration of Helsinki.  </p>

<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1816102/pdf/brmedj02559-0071.pdf">Original version from 1964</a></li>
<li><a href="http://www.wma.net/en/30publications/10policies/b3/index.html.pdf?print-media-type&amp;footer-right=%5Bpage%5D/%5BtoPage%5D">Current version 2008</a>.<br/>
    * Note procedural components, e.g. ¶15  This comes from the first revision in 1975</li>
<li>Controveries, e.g. use of placebos as controls in poor countries.  (See Fourth revision)
    * Note the use of words like &ldquo;any&rdquo; and &ldquo;all&rdquo;, e.g. &ldquo;not be subject to any risk&rdquo; in ¶32
    * Right to share in &ldquo;any&rdquo; benefits that result from it ¶33</li>
</ul></li>
</ul>

<p>GROUP DISCUSSION QUESTIONS: <a href="../Activities/ethics-discussion.pdf">handout</a></p>

<h1>Age Adjustment Activity</h1>

<p>From Tuesday</p>

<h1>Live Expectancy Activity</h1>

<p>From Tuesday</p>

</body>

</html>

